NFKB1 and familial pancreatic carcinoma: Moreover, many chemotherapeutic agents, including gemcitabine, have been reported to activate NF-κB [21]; inhibiting NF-κB alongside chemotherapy holds promise as a new therapeutic strategy against pancreatic cancer.